2016 Oklahoma Statutes
Title 63. Public Health and Safety
§63-2-803. Approved cannabidiol for use in clinical trials.
A. Clinical trials conducted pursuant to a statewide investigational new drug application established pursuant to the provisions of this act shall only utilize cannabidiol which is:
1. From an approved source; and
2. Approved by the United States Food and Drug Administration to be used for treatment of a condition specified in an investigational new drug application.
B. The principal investigator and any subinvestigator may receive cannabidiol directly from an approved source or authorized distributor for an approved source for use in the clinical trials.
Added by Laws 2015, c. 203, § 5, emerg. eff. April 30, 2015.
Disclaimer: These codes may not be the most recent version. Oklahoma may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
